Navigation Links
Medstrat Announces Record Sales Year
Date:1/21/2011

DOWNERS GROVE, Ill., Jan 21, 2011 /PRNewswire/ -- Medstrat, a pioneer in medical imaging for almost 15 years and the leading developer of FDA-approved orthopedic multi-platform PACS and imaging solutions, announces record sales for the year ended December 31, 2010. During the year, Medstrat added over 100 new PACS customers to its already significant base of orthopedic practices throughout the United States. As a result, both sales revenue and net income hit record levels. According to Michael Cowden, Medstrat's President & CEO, "Our strong performance in 2010 is a direct result of the team we have here in place at Medstrat. Truly caring about our customers is what we are all about.  It is our culture and it is directly influencing our growth, especially in light of the tremendous number of referral opportunities available due to recent failures by large competitors and continued ownership changes by others." According to Mr. Cowden, PACS conversions represent a significant percentage of current business and will continue to do so throughout 2011.  He also attributes recent success to continued strong business relationships throughout the orthopedic PACS industry.

About Medstrat

Medstrat originated digital x-ray imaging for orthopedic practices to meet the unique needs of the orthopedic surgeon and address the demanding challenges orthopedic surgeons face every day, including the pressure to reduce costs and deliver faster, higher-quality patient care. Based upon a proven, high-performing digital medical imaging platform, Medstrat allows for the elimination of film, chemicals, and processing, increases workflow efficiency and staff productivity, and provides significant cost savings. For more information, call 800-882-4224 or visit www.medstrat.com.


'/>"/>
SOURCE Medstrat
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Medstrat Partners with Major Orthopedic Company
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
(Date:5/23/2016)... Non-invasive diagnostic test realizes the ... ,Technology to be presented at Yissum’s booth, at IATI-BIOMED ... Company of the Hebrew University of Jerusalem announced ... Aurum Ventures MKI, the technology investment arm of Morris ... approach for early detection of multiple diseases by analyzing ...
(Date:5/23/2016)... -- Gamida Cell, a leader in cellular ... orphan genetic diseases, announced today it has been awarded ... Israel Innovation Authority (formerly the Office of the Chief ... The mission of the Israel Innovation Authority is to ... and technology, while stimulating economic growth. The ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food and Drug ... in both men and women. To date, the company is the first and only ... any adult who suffers with androgenetic alopecia. , “This new level of clearance ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The 12th ... 6pm to 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech ... be led by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Heart Association/American Stroke Association's Get With The Guidelines®-Stroke Gold Plus Achievement Award ... a second for Memorial Healthcare System, recognizes its commitment to emergency stroke ...
(Date:5/25/2016)... ... 2016 , ... “We are very pleased to welcome Brad ... brings significant experience advising healthcare provider clients throughout the country. As the transition ... MACRA, we believe that continuing to add professionals with deep experience from a ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... all Georgia and Tennessee locations to streamline patient check-in and post visit surveys. ... our approach to patient care. It has revolutionized the check-in process for our ...
Breaking Medicine News(10 mins):